Mettler-Toledo International, Inc.

MTD Healthcare Diagnostics & Research

Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024.

Revenue
+6.27%
EPS
+16.2%
Free cash flow
+33.0%
Total debt
−8.42%

Quarter to September 2026, against a year earlier

1,746.95 67.87 +4.04%
Market cap
$33.6B
P/E
37.7×
Fwd P/E
36.1×
Dividend yield
—
F-score
5/9
Altman Z
10.23
Beneish M
−2.44
Dividend safety
n/a
Sep '26 From the 10-Q filed 6 Nov Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
32.66 28.68 29.50 33.01

+8 more quarters

P/S ratio
7.18 6.22 6.26 7.14
P/FCF ratio
34.55 29.75 32.23 33.86
P/Operating CF
97.76 82.81 183.02 127.38
P/B ratio
388.41 2,004.62 0.00 0.00
EV/Sales
7.65 6.72 6.79 7.65
EV/EBITDA
24.62 21.27 22.13 24.77
EV/FCF
36.80 32.14 34.96 36.32
Current Ratio
1.10 1.12 1.20 1.14
Net Debt/EBITDA
0.00 5.93 8.36 5.54
Debt/Equity
26.06 164.70 (53.21) (91.05)
Earnings Yield
3.06% 3.49% 3.39% 3.03%
Free Cash Flow Yield
2.89% 3.36% 3.10% 2.95%
Free Cash Flow per Share
15.46 14.05 6.03 8.93
Book value per Share
3.89 0.64 (2.06) (1.15)
Free Cash Flow
308.57 282.62 122.38 184.08
EV/EBIT
27.37 23.65 24.66 27.55
Other line items

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026